Registry to Evaluate the Efficacy of Zotarolimus-Eluting Stent

UnknownOBSERVATIONAL
Enrollment

4,000

Participants

Timeline

Start Date

January 31, 2009

Primary Completion Date

January 31, 2012

Conditions
Coronary Artery Disease
Interventions
DEVICE

Endeavor Resolute stents

2nd generation ZES

DEVICE

Endeavor Sprint stent

1st generation ZES

Trial Locations (19)

Unknown

NOT_YET_RECRUITING

Hallym University Sacred Heart Hospital, Anyang

NOT_YET_RECRUITING

Yongnam University Medical Center, Daegu

NOT_YET_RECRUITING

Chungnam National University Hospital, Daejeon

NOT_YET_RECRUITING

Chonbuk National Univesity Hospital, Iksan

NOT_YET_RECRUITING

Inje University Ilsan Paik Hospital, Ilsan

RECRUITING

National Health Insurance Corporation Ilsan Hospital, Ilsan

NOT_YET_RECRUITING

Gachon Kil Medical Center, Inchon

RECRUITING

Inha University Hospital, Inchon

NOT_YET_RECRUITING

Gyeongsang National University Hospital, Jinju

NOT_YET_RECRUITING

Pusan National University Hospital, Pusan

NOT_YET_RECRUITING

Bundang CHA Medical Center, Seongnam

NOT_YET_RECRUITING

Seoul National University Bundang Hospital, Seongnam

NOT_YET_RECRUITING

Gangbuk Samsung Hospital, Seoul

NOT_YET_RECRUITING

Kangdong Sacred Heart Hospital, Seoul

RECRUITING

Seoul Boramae Hospital, Seoul

RECRUITING

Seoul National University Hospital, Seoul

NOT_YET_RECRUITING

Soonchunhyang University Hospital, Seoul

NOT_YET_RECRUITING

St. Vincent's Hospital, Suwon

NOT_YET_RECRUITING

Uijeongbu St. Mary's Hospital, Uijeongbu-si

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Medtronic

INDUSTRY

lead

Seoul National University Hospital

OTHER

NCT00960908 - Registry to Evaluate the Efficacy of Zotarolimus-Eluting Stent | Biotech Hunter | Biotech Hunter